Moreover, it has been reported that miR-126 inhibits apoptosis of acute myeloid leukemia (AML) cells and enhanced the colony-forming ability of mouse bone marrow progenitor cells through targeting Polo-like kinase 2 (PLK2), a tumor suppressor [21]. Here, PLK2 is linked to acute myeloid leukemia.